U.S. Platelet Rich Plasma (prp) Market Size & Outlook
U.S. platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
U.S. platelet rich plasma (prp) market highlights
- The U.S. platelet rich plasma (prp) market generated a revenue of USD 245.5 million in 2023 and is expected to reach USD 493.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10.5% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2023 | USD 245.5 million |
| Market revenue in 2030 | USD 493.8 million |
| Growth rate | 10.5% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.9% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 178.1 million by 2030.
Pure prp was the largest segment with a revenue share of 51.57% in 2023. Horizon Databook has segmented the U.S. platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is recognized as the largest contributor to revenue generation in the global PRP market. The local presence of a large number of leading manufacturers that focus on the development of novel PRP preparation systems is expected to contribute to market growth.
High adoption of platelet-rich plasma treatments across key end-use settings, such as hospitals & clinics, and growing adoption by offices or physician clinics are expected to expand the PRP market in the U.S.
Supportive regulatory authorities are further driving the market in the country. The U.S. FDA's Center for Biologics Evaluation and Research (CBER) is the regulatory body responsible for PRP products. The CBER grants 510(k) application approval for the marketing of PRP preparation systems in the U.S. Most of the currently available PRP plasma preparation systems have 510(k) FDA clearance.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
U.S. Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
